Physician profile
Marc Edward Mani
NPI 1912040296
$2,597.67
in general payments reported to CMS, 2019-2025
11 companies · $879 in 2025
The $879 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $315 · 2021: $159 · 2022: $281 · 2023: $74.96 · 2024: $577 · 2025: $879.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,530.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $780.20 | 2024-2025 | |
| Tepha INC | $436.55 | 2019-2020 | |
| Merz North America, INC. | $229.81 | 2019-2025 | |
| Sientra, INC. | $184.15 | 2022 | |
| Integra Lifesciences Corporation | $173.72 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medtronic, INC. | $171.32 | 2022-2023 | Ligasure |
| Galderma Laboratories, L.P. | $163.37 | 2025 | |
| Bard Peripheral Vascular, INC. | $158.99 | 2021 | |
| Axogen | $138.70 | 2025 | |
| Allergan, INC. | $124.95 | 2019 | |
| Coopersurgical, INC. | $35.91 | 2025 | Onetrac Lx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Mani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.